Economic Evaluation of Nirmatrelvir/Ritonavir Among Adults Against Hospitalization During the Omicron Dominated Period in Malaysia: A Real-World Evidence Perspective is a research paper published in Drugs - Real World Outcomes (2024). On theSindex it has a DataRank of 0. It has been cited 9 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
Kementerian Kesihatan Malaysia
Grant: NIH/800-3/2/2 Jilid 13 (182)
FWCI
2.74
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords